Mark Alles

Mark Alles

President at
Acetylon Pharmaceuticals, Inc.
66 year
Health Technology
Commercial Services
Consumer Services

Profile

Mark J. Alles is on the board of Syros Pharmaceuticals, Inc., Juno Therapeutics, Inc., Antengene Corporation Co., Ltd. and Antengene Corp. Ltd. In the past he was Chairman, President, CEO & COO at Celgene Corp., Principal at Centocor, Inc., Principal at Bayer Corp. and Vice President-Oncology Business Unit at Aventis Pharmaceuticals, Inc. Mr. Alles received an undergraduate degree from Lock Haven University of Pennsylvania.

Mark Alles active positions

CompaniesPositionStart
President -
Chairman 10/05/2023
Chairman 09/01/2024
Director/Board Member -
Chairman 08/08/2023

Former positions of Mark Alles

CompaniesPositionEnd
BIOMARIN PHARMACEUTICAL INC. Director/Board Member 21/05/2024
SYROS PHARMACEUTICALS, INC. Director/Board Member 30/09/2023
ANTENGENE CORPORATION LIMITED Director/Board Member 14/04/2023
TURG POIN Chairman 17/08/2022
░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Mark Alles's experience

Training of Mark Alles

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Technology Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!